Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1980 Jun;35(6):441–445. doi: 10.1136/thx.35.6.441

Plasma and sputum erythromycin concentrations in chronic bronchitis.

G E Marlin, P R Davis, J Rutland, N Berend
PMCID: PMC471307  PMID: 7434299

Abstract

Plasma and sputum concentrations of erythromycin were measured in 10 patients with chronic bronchitis during an eight-day course of a new formulation of erythromycin stearate. The plasma erythromycin levels compared favourably with the minimal inhibitory concentrations for common respiratory pathogens and indicated adequate gastrointestinal absorption when the drug was taken immediately before food. Sputum erythromycin levels were variable and in some patients low or undetectable. Measurable sputum erythromycin levels were approximately 10% of plasma levels with no evidence of accumulation and were of similar order of magnitude to the minimal inhibitory concentrations for common respiratory pathogens except Haemophilus influenzae. There was no correlation between sputum and plasma erythromycin levels. There was a trend for higher erythromycin levels in sputum containing increasing amounts of pus and also when plasma levels increased.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell S. C., Hamman J. W., Grundy W. E. Micromethod for assaying serum levels of erythromycin. Appl Microbiol. 1969 Jan;17(1):88–92. doi: 10.1128/am.17.1.88-92.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berend N., Rutland J., Marlin G. E. Plasma and saliva concentrations for a new formulation of erythromycin stearate. Curr Med Res Opin. 1979;6(2):118–123. doi: 10.1185/03007997909109408. [DOI] [PubMed] [Google Scholar]
  3. Campbell M. J. Tetracycline levels in bronchial secretions. J Clin Pathol. 1970 Jul;23(5):427–434. doi: 10.1136/jcp.23.5.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gould J. C. Erythromycin in respiratory tract infection. Scott Med J. 1977 Dec;22(5):355–359. doi: 10.1177/00369330770220S103. [DOI] [PubMed] [Google Scholar]
  5. HAFEZ F. F., STEWART S. M., BURNET M. E. PENICILLIN LEVELS IN SPUTUM. Thorax. 1965 May;20:219–225. doi: 10.1136/thx.20.3.219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. HERS J. F., MULDER J. The mucosal epithelium of the respiratory tract in muco-purulent bronchitis caused by Haemophilus influenzae. J Pathol Bacteriol. 1953 Jul;66(1):103–108. doi: 10.1002/path.1700660114. [DOI] [PubMed] [Google Scholar]
  7. Hartnett B. J., Marlin G. E. Doxycycline in serum and bronchial secretions. Thorax. 1976 Apr;31(2):144–148. doi: 10.1136/thx.31.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lacey R. W. A new look at erythromycin. Postgrad Med J. 1977 Apr;53(618):195–200. doi: 10.1136/pgmj.53.618.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MAY J. R., DELVES D. M. AMPICILLIN IN THE TREATMENT OF HAEMOPHILUS INFLUENZAE INFECTIONS OF THE RESPIRATORY TRACT. Thorax. 1964 Jul;19:298–305. doi: 10.1136/thx.19.4.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MAY J. R., DELVES D. M. TREATMENT OF CHRONIC BRONCHITIS WITH AMPICILLIN: SOME PHARMACOLOGICAL OBSERVATION. Lancet. 1965 May 1;1(7392):929–933. doi: 10.1016/s0140-6736(65)91253-5. [DOI] [PubMed] [Google Scholar]
  11. MacCulloch D., Richardson R. A., Allwood G. K. The penetration of doxycycline, oxytetracycline and minocycline into sputum. N Z Med J. 1974 Oct 9;80(525):300–302. [PubMed] [Google Scholar]
  12. May J. R., Ingold A. Amoxycillin in the treatment of chronic non-tuberculous bronchial infections. Br J Dis Chest. 1972 Jul;66(3):185–191. doi: 10.1016/0007-0971(72)90029-0. [DOI] [PubMed] [Google Scholar]
  13. Mårdh P. A. Human respiratory tract infections with mycoplasmas and their in vitro susceptibility to tetracyclines and some other antibiotics. Chemotherapy. 1975;21 (Suppl 1):47–57. doi: 10.1159/000221891. [DOI] [PubMed] [Google Scholar]
  14. Nadkarni M. S., Shah P. A., Thakurdesai S. Treatment of acute bacterial infections of the upper respiratory tract. Curr Med Res Opin. 1977;4(8):544–554. doi: 10.1185/03007997709115269. [DOI] [PubMed] [Google Scholar]
  15. Neaverson M. A. Intravenous administration of erythromycin: serum, sputum and urine levels. Curr Med Res Opin. 1976;4(5):359–364. doi: 10.1185/03007997609109329. [DOI] [PubMed] [Google Scholar]
  16. Nicholas P. Erythromycin: clinical review I. Clinical pharmacology. N Y State J Med. 1977 Nov;77(13):2088–2094. [PubMed] [Google Scholar]
  17. Stewart S. M., Anderson I. M., Jones G. R., Calder M. A. Amoxycillin levels in sputum, serum, and saliva. Thorax. 1974 Jan;29(1):110–114. doi: 10.1136/thx.29.1.110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Stewart S. M., Fisher M., Young J. E., Lutz W. Ampicillin levels in sputum, serum, and saliva. Thorax. 1970 May;25(3):304–311. doi: 10.1136/thx.25.3.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Watson G. I. The treatment of Mycoplasma pneumoniae infections. Scott Med J. 1977 Dec;22(5):361–365. doi: 10.1177/00369330770220S104. [DOI] [PubMed] [Google Scholar]
  20. Willey R. F., Gould J. C., Grant I. W. A comparison of ampicillin, erythromycin and erythromycin with sulphametopyrazine in the treatment of infective exacerbations of chronic bronchitis. Br J Dis Chest. 1978 Jan;72(1):13–20. doi: 10.1016/0007-0971(78)90003-7. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES